Centessa Pharmaceuticals (NASDAQ:CNTA) Price Target Raised to $28.00
Centessa Pharmaceuticals (NASDAQ:CNTA – Free Report) had its target price increased by Guggenheim from $24.00 to $28.00 in a report published on Friday,Benzinga reports. Guggenheim currently has a buy ...
Celcuity (NASDAQ:CELC) Receives “Buy” Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a research report released on Friday morning,Benzinga reports. The firm currently has a $27.00 price target ...